India markets open in 5 hours 48 minutes

Cipla Limited (CIPLA.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
784.95-24.20 (-2.99%)
At close: 3:30PM IST

Cipla Limited

Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai 400013
91 22 2482 6000

IndustryDrug Manufacturers—General
Full-time employees25,845

Key executives

NameTitlePayExercisedYear born
Mr. Umang VohraMD, Global CEO & Exec. Director135.6MN/A1971
Ms. Samina HamiedExec. Vice-Chairperson67.5MN/A1976
Mr. Kedar Upadhye CS, MBAGlobal Chief Financial Officer26.5MN/A1977
Mr. Rajendra ChopraCompliance Officer & Company Sec.15.3MN/AN/A
Dr. Raju Sunil Mistry M.A., Ph.D.Pres & Global Chief People OfficerN/AN/A1965
Mr. Pradeep BhadauriaPres & Chief Scientific OfficerN/AN/AN/A
Ms. Geena V. MalhotraGlobal Chief Technology OfficerN/AN/AN/A
Mr. Naveen BansalHead of Investor RelationsN/AN/AN/A
Mr. Gautam RohidekarChief Legal OfficerN/AN/AN/A
Ms. Heena KanalVP of Corp. CommunicationsN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.


Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. It also provides respiratory products, including inhalers and nasal sprays, as well as other dosage forms consists of injectables and biosimilars. Cipla Limited has collaboration with CSIR-Indian Institute of Chemical Technology for the development of medication for the treatment of COVID-19; and partnership with Karwa Ltd. for the commercialization of antibody detection kits for COVID-19, as well as the Premier Medical Corporation Private Limited for the commercialization of the rapid antigen test kits for COVID-19. The company was founded in 1935 and is headquartered in Mumbai, India.

Corporate governance

Cipla Limited’s ISS governance QualityScore as of 2 December 2020 is 5. The pillar scores are Audit: 1; Board: 2; Shareholder rights: 5; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.